Delcath Systems (DCTH) Gains from Investment Securities (2013 - 2024)
Delcath Systems' (DCTH) quarterly Gains from Investment Securities came in at $6.7 million in Q4 2024, up 3055.31% year-on-year from $211674.9 in Q1 2024, and up 324.5% quarter-over-quarter from -$3.0 million in Q3 2024.
Delcath Systems (DCTH) Gains from Investment Securities (2013 - 2024) Analysis & Trends
Delcath Systems' Gains from Investment Securities history runs 10 years deep, the most recent figure standing at $6.7 million for Q4 2024.
- On a quarterly basis, Gains from Investment Securities rose 3055.31% year-over-year to $6.7 million in Q4 2024; TTM through Sep 2025 was $6.7 million, a 6.8% decrease from a year earlier, with the FY2024 full-year figure at $14.1 million, up 75.93% from the prior year.
- Gains from Investment Securities climbed to $6.7 million in Q4 2024 per DCTH's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $9.8 million in Q2 2024 and bottomed at -$3.0 million in Q3 2024.
- The 3-year median for Gains from Investment Securities is $1.7 million (2020), against an average of $3.1 million.
- Across the five-year window, Gains from Investment Securities surged 40557.14% in 2020 and plunged 131.7% in 2024, its largest moves.
- Year by year, Gains from Investment Securities stood at $2.8 million in 2020, then slumped by 107.98% to -$226000.0 in 2023, then jumped by 3055.31% to $6.7 million in 2024.
- Per Business Quant, the three latest DCTH Gains from Investment Securities figures stand at $6.7 million (Q4 2024), -$3.0 million (Q3 2024), and $9.8 million (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Delcath Systems | 432.25 Mn | 342.96 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.68 Mn |
| Dec 31, 2024 | 6.68 Mn |
| Sep 30, 2024 | -2.98 Mn |
| Sep 30, 2024 | -2.98 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 612,000.00 |
| Mar 31, 2024 | 612,000.00 |
| Dec 31, 2023 | -226,000.00 |
| Dec 31, 2023 | -226,000.00 |
| Sep 30, 2023 | 9.38 Mn |
| Sep 30, 2023 | 9.38 Mn |
| Jun 30, 2023 | -1.16 Mn |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2020 | 2.83 Mn |
| Mar 31, 2020 | 2.83 Mn |
| Dec 31, 2019 | -17.04 Mn |
| Dec 31, 2019 | -17.04 Mn |
| Sep 30, 2019 | -434,000.00 |
| Sep 30, 2019 | -434,000.00 |